Introduction {#Sec1}
============

Cochlear implants (CI) are neural prostheses used to restore hearing; they represent a remarkable success saga in medicine. Today, they bring many patients back into a world of hearing. Moreover, electric stimulation can provide a basis for pre-lingual deaf children to understand and develop oral speech. The results depend on the existence and maintenance of a cochlear nerve.

Despite the loss of sensory receptors and adjoining dendrites, CI function can persist, implying that human spiral ganglion neurons (SGNs) maintain electric excitability even after years of "silent inactivity". Their remarkable resistance to degeneration is verified in histological studies in which, unlike in animals, SGNs can persist as mono-polar or "amputated" cells lacking peripheral dendrites and being completely disconnected from the organ of Corti (Teufert et al. [@CR41]).

Here, we focus on satellite glial cells (SGCs) that tightly surround neurons in sensory ganglia and human SGNs. The cells were analyzed for gap junction (GJ) intercellular channels and connexin 43 (Cx43) expression by using transmission electron microscopy (TEM) and laser confocal immunohistochemistry. Comparisons were made with another mammal (guinea pig). We speculate that Cx43-mediated GJ signaling between SGCs plays a key role in the protection and maintenance of the human auditory nerve.

Materials and methods {#Sec2}
=====================

Studies of human materials were approved by the local ethics committee (no. 99398, 22/9 1999, cont., 2003, Dnr. 2013/190) and patient consent was obtained. Investigations of animal cochlea were approved by the local ethics committee (no. C254/4, C209/10). All studies adhered to the rules of the Helsinki declaration. Six Dunkin Hartley guinea pigs (female, 1--2 months) were used. The same procedures as those for human specimen processing were undertaken for the fixation and immunohistochemistry of the animal cochleae.

TEM analysis {#Sec3}
------------

The TEM analyses of human spiral ganglion (SG) and SGCs were based on ten human cochleae processed during the last 15 years (Rask-Andersen et al. [@CR35]). The specimens were analyzed at inner ear research laboratories in both Uppsala and Innsbruck. Tissue was rinsed in cacodylate buffer (Christine Gröpl \[R1104\], Tulln, Austria), followed by fixation with 1 % osmium tetraoxide (Christine Gröpl \[R1015\]) in 0.05 M cacodylate buffer at 4 °C for 4 h. Excessive osmium tetraoxide was removed by rinsing the specimens again in cacodylate buffer. Small-sized diamond drills were used to mill off cochleae surrounding the bone. Subsequently the cochleae were decalcified in 20 % ethylene-diamine-tetra-acetic acid (Titriplex III, Merck \[108421\], Darmstadt, Germany), pH 7.4, for 6 weeks. After decalcification, a mid-modiolar section was made and the two halves were then dehydrated in an increasing ethanol series and acetone prior to incubation in a dilution of liquid epoxy resin (Epon medium mixture: 20 ml EMbed-812, 16 ml dodecenyl succinic anhydride, 8 ml nadic methyl anhydride, 1.2 ml benzyldimethylamine; Electron Microscopy Sciences, Munich, Germany) and acetone at a ratio of 30 %--70 % for 3 h. The specimens were infiltrated with a mixture of Epon and acetone in equal proportions at 4 °C overnight in closed vials. The next day, a mixture of 70 % epoxy resin and 30 % acetone replaced the liquid for 3 h. Subsequently, tissue samples were incubated twice in 100 % Epon at 4 °C for 3 h and overnight. Then, the pure epoxy resin was changed and the specimens were infiltrated with Epon in a vacuum chamber for 4 h. The specimens were subsequently transferred to an embedding mold, labeled and placed in a vacuum chamber for an additional 2 h followed by incubation in a chamber at 60 °C for 24 h to increase the polymerization of the epoxy resin. Sections at a thickness of 1 μm were cut on a Leica UC6 microtome, lightly stained with toluidine blue at 60 °C and then examined by using a light microscope.

For TEM analysis, specimens were then trimmed and ultrathin sections (90 nm thickness) were acquired and transferred to pioloform F (polyvinylacetate)-coated slot grids. Staining was performed within an automated system (Leica EM Stain) with uranyl acetate (5 g/l for 30 min) and lead citrate (5 g/l for 50 min) at 25 °C.

The various turns of the cochlea were analyzed and the SG from the lower basal, upper basal, lower middle, and upper middle regions was sectioned separately. Special attention was given to the structural relationship between the surrounding SGCs and Type I neurons. Sections were viewed in a JEOL 100 SX electron microscope (Uppsala) and in Zeiss LIBRA (Institute of Zoology, Innsbruck) and Philips CM 120 (Division of Anatomy, Histology and Embryology, Innsbruck) transmission electron microscopes.

### Control of antibody specificity against connexin 43 {#Sec4}

We used the following controls:Positive controlsGuinea pig cerebellumGuinea pig heart tissueGuinea pig trigeminal ganglionHuman cochlear tissue: (a) lateral wall, (b) organ of CortiHuman cochlear nerve (transitional zone)Negative controlsGuinea pig spiral ganglionPrimary antibody omission

First, positive immunostaining characteristics were analyzed in the guinea pig lateral cochlear wall and compared with the spiral and trigeminal ganglion and cerebellum. Secondly, two different types of antibodies were used that targeted phosphorylation properties of the protein residues. These antibodies were tested on guinea pig heart muscle (Fig. [1d](#Fig1){ref-type="fig"}, [e](#Fig1){ref-type="fig"}). Thirdly, negative controls were carried out by omitting the primary antibody. Finally, the staining properties of the transitional zone of the auditory nerve were studied.Fig. 1Immunohistochemistry of the human inner ear and technical controls in guinea pig cerebellum, heart and trigeminal and spiral ganglia. **a** Immunohistochemistry of guinea pig cerebellum. Neural marker TUJ1 (tubulin *green*) stains Purkinje cells and nerve processes. Expression of myelin basic protein (MBP *red*) is seen in the central axon but not in the peripheral nerve processes. **b** In the guinea pig spiral ganglion, the Schwann cells surrounding the perikarya express MBP. **c** Positive Cx43 reaction in guinea pig trigeminal ganglion cell bodies. Reaction product occurs as *dots* (*arrow*) and represents gap junction intercellular channels between individual glial cells (*asterisks* trigeminal ganglion neurons). *Inset* in **c** Ganglion cell bodies are TUJ1-positive and surrounded by unmyelinated satellite cells that are immune-positive for S-100. **d**, **e** Immunolabeling with two different antibodies (ab1 and ab2; Table [1](#Tab1){ref-type="table"}) against connexin 43 (Cx43) in guinea pig heart muscle. **f**, **g** Positive immunoreaction for Cx43 (*green*) and Cx30 (*red*) in the human spiral ligament and stria vascularis. The connexin reactivity is seen both separately and co-expressed. **h** Cx43 expression in central glia in the transitional zone of the human auditory nerve. *Bars* 100 μm (**a--c**, *inset* in **c**), 15 μm (**d**, **e**), 25 μm (**f**, **g**), 20 μm (**h**)

Cochlear fixation and sectioning of human cochlea {#Sec5}
-------------------------------------------------

The study is based on 5 human (2 male, 3 female; ages: 45--56 years) cochleae removed during surgery. The cochleae were taken from patients with giant petro-clival meningioma, a life-threatening condition and were dissected out during a trans-cochlear operation. Most of the ears had normal pure tone thresholds before the operation. The mean pure tone thresholds (PTA) were below 15 dB in four patients. In one patient, values were between 25 dB and 35 dB at 2000 Hz and over. The cochleae were dissected out and immediately placed in 4 % para-formaldehyde (PFA) in 0.1 M phosphate-buffered saline (PBS; pH 7.4). At the starting point of the fixation, the cochleae were gently perfused with fixative with a small cannula. After 24 h of fixation, the fixative was replaced with 0.1 M PBS and decalcification of the cochleae was carried out in 0.1 M Na-EDTA in phosphate buffer at pH 7.2. Four weeks later, the decalcified cochleae were rinsed with PBS and made ready for frozen sectioning. The cochleae were embedded in Tissue-Tek O.C.T. (Poly-sciences, Warrington, Pa., USA) and sectioned in a cryostat at 8--10 μm. The sections were collected on gelatin-chrome coated slides and stored below −70 °C.

Immunohistochemistry {#Sec6}
--------------------

Antibodies against Cx43, glial cell marker S-100, myelinating glial cell marker myelin basic protein (MBP) and neuron marker TUJ1 (tubulin) were employed for immunohistochemistry on the human cochlear sections in both a single- and double-staining fashion. Table [1](#Tab1){ref-type="table"} shows the combinations, dilutions and sources of the major antibodies used in the study. Incubation of the sections with single or mixed antibodies was carried out under the protocol as previously reported (Liu et al. [@CR21], [@CR22], [@CR23]). Briefly, sections covered with antibody solution were placed in an atmosphere at 4 °C for 20 h. Sections used as negative controls in each experiment were incubated with 2 % bovine serum albumin (BSA) instead of antibodies. After incubation with primary antibodies or BSA, the sections were rinsed with PBS (3 × 5 min). Sections were subjected to reaction with Alexa Fluor 488 and 555 (Molecular Probes) conjugated to secondary antibodies (Invitrogen, USA), for 2 h at room temperature. This was followed by counterstaining with DAPI (4′,6-diamidino-2-phenylindole; Invitrogen, USA; lot no. 474302) for 5--7 min at room temperature. Sections were mounted with Vectashield (Vector Labs). As a positive Cx43 antibody control, frozen sections of guinea pig trigeminal ganglion and cerebellum were obtained by using the same methods as those used for obtaining human cochlear sections. We employed trigeminal ganglion for positive antibody control because Cx43 expression has been reported in the nociceptive ganglion of rodents (trigeminal ganglion, Vit et al. [@CR43]; dorsal root ganglion, Procacci et al. [@CR34]).Table 1Antibody characteristics and combinations (*Cx43* connexin 43, *MBP* myelin basic protein)AntibodiesDilutionsCharacteristicsHostsAnti-Cx43 (ab1; cat. no. 13--8300, Zymed), anti-tubulin (Chemicon)1:200, 1:200Polyclonal, monoclonalRabbit, mouseAnti-Cx43 (ab2; cat. no. MAB 3068, Millipore), anti-tubulin (Chemicon)1:200, 1:200Polyclonal, monoclonalMouse, rabbitAnti-Cx43 (ab1; cat. no. 13--8300, Zymed), anti-MBP (Sigma)1:100, 1:100Polyclonal, monoclonalRabbit, ratAnti-S100 (DAKO), anti-tubulin (Chemicon)1:300, 1:200Polyclonal, monoclonalRabbit, mouse

For additional immunohistochemistry of the human spiral ganglion, we used antibodies against c-Ret (rearranged during transfection, a receptor for the glial-cell-line-derived neurotrophic factor \[GDNF\] family ligand \[GFL\]), i.e., monoclonal antibody from mouse RET01 (cat. no. sc-57431, Santa Cruz Biotechnology), polyclonal antibody from rabbit c-19 (cat. no. sc-167, Santa Cruz Biotechnology), polyclonal antibody from goat c-20 (cat. no sc-1290, Santa Cruz Biotechnology) and rabbit polyclonal antibody to Ret phospho S696 (cat. no. ab4726, Abcam). The GDNF family receptor alpha 1 (GFRalpha1) antibodies that we used included a polyclonal antibody from rabbit (cat. no. AB5140, Millipore; dilution 1:50) and GFRalpha1 polyclonal antibody N-18 from goat (cat. no. sc-6156; Santa Cruz Biotechnology). The GFRalpha2 antibody (H-89) was a rabbit polyclonal antibody (cat. no. sc-28953, Santa Cruz Biotechnology; dilution 1:50). Neurturin antibody was a rabbit polyclonal antibody (cat. no. ab49203, Abcam) and has no cross reactivity with GDNF. GDNF (B-8) antibody was a monoclonal antibody from mouse (cat. no. sc-13147, Santa Cruz Biotechnology; dilution 1:50). Persephin (PSPN) antibody was a mouse monoclonal antibody (cat. no. MAB2388, R&D; dilution 1:100). Artemin (Artn) antibody was a goat polyclonal antibody (cat. no. sc-9329, Santa Cruz; dilution 1:100). This information is taken in part from Liu and Rask-Andersen ([@CR20]).

Confocal, fluorescent and bright-field imaging {#Sec7}
----------------------------------------------

Bright-field images were used to identify the inner ear structures. Fluorescent images were obtained by using an inverted fluorescent microscope (Nikon TE2000, Japan) equipped with a fluorescence unit and a digital camera with three filters (for emission spectra at 358, 461 and 555 nm) and connected to a computer system including image-merging software. For confocal microscopy, we used a Nikon TE2000 microscope equipped with a laser imaging system having three different filters. A computer-based program, EZ-C1, was used for storing images and reconstructing z-stack images into three-dimensional (3-D) images. All images were saved as uncompressed JPG files.

Results {#Sec8}
=======

Guinea pig {#Sec9}
----------

Immunohistochemical expression of MBP, neural marker TUJ1, S-100 and connexin 43 were verified in guinea pig cerebellum, heart muscle and trigeminal and spiral ganglia (Fig. [1](#Fig1){ref-type="fig"}). The spiral ganglion cell bodies were TUJ1-positive and surrounding Schwann cells (SCs) expressed MBP (Fig. [1b](#Fig1){ref-type="fig"}). The trigeminal ganglion cell bodies were TUJ1-positive and surrounded by unmyelinating satellite cells expressing S-100 (Fig. [1c](#Fig1){ref-type="fig"}, inset). These cells expressed Cx43 and the reaction product appeared as dots representing GJ channels between separate glial cells.

Two different antibodies (ab1 and ab2) targeting the phosphorylation properties of the protein residues of Cx43 were tested in guinea pig heart muscle (Fig. [1d](#Fig1){ref-type="fig"}, [e](#Fig1){ref-type="fig"}). Both antibodies labeled connexin 43 but with a slightly different appearance. MBP and TUJ1 expression was seen in the trigeminal ganglion of the guinea pig (Fig. [2a](#Fig2){ref-type="fig"}, [b](#Fig2){ref-type="fig"}). Nerve fibers were MBP-positive but no MBP expression was seen in SGCs surrounding neural perikarya (Fig. [2a](#Fig2){ref-type="fig"}). SGCs expressed Cx43 (Fig. [2b](#Fig2){ref-type="fig"}). Guinea pig spiral ganglion cells showed no expression of Cx43 (Fig. [2c](#Fig2){ref-type="fig"}).Fig. 2Cx43 immunohistochemistry in trigeminal and spiral ganglion of the guinea pig. **a** MBP and TUJ1 expression in the trigeminal ganglion of the guinea pig. Nerve fibers are MBP-positive (*red*) with no MBP expression in SGCs surrounding neural cell bodies (*green*). **b** SGCs express Cx43 (*arrow*, *green* *dots*). Red represents TUJ1. **c** Guinea pig SGNs are TUJ1-positive but show no expression of Cx43. *Inset* SGN at higher magnification. *Bars* 100 μm (**a**), 20 μm (**b**), 50 μm (**c**)

Human {#Sec10}
-----

Various cell types in the spiral ganglion were identified by using specific markers including MBP, TUJ1, S-100 and Cx43 immunoreactivity. Double-immunostaining was used with a combination of cell marker antibodies. The antibody for MBP stained the myelin sheath of the nerve fibers, whereas SGCs surrounding the spiral neuron cell bodies were labeled with S-100 (not illustrated) and Cx43 antibody (Fig. [3](#Fig3){ref-type="fig"}). Immunohistochemistry showed TUJ1-positive cell bodies and axonal processes expressing TUJ1 and MBP. Axons near the cell body (axon hillock approximately 50 μm long) often lacked MBP expression. Cx43 expression along the peripheral border of neuronal soma in SG appeared as small dots and represented GJ plaques between surrounding SGCs (Fig. [3c](#Fig3){ref-type="fig"}--[e](#Fig3){ref-type="fig"}). Intercellular GJs, expressing Cx43, were found both between SGCs enveloping the same SGN body and amid different neuronal bodies. Cx43 expression suggested that this protein was the main component of GJ channels in SGCs. 3-D video reconstruction showed that Cx43 was located peripherally around the perikarya of the type I cell ([Supplementary material](#Sec13){ref-type="sec"}).Fig. 3Light microscopy, transmission electron microscopy (TEM) and immunofluorescence of human spiral ganglion (SG). **a** Semi-thin section of a normal human SG fixed in Karnovsky's fixative (petroclival meningioma, normal audiogram, osmium/toluidine staining). Spiral ganglion neuron (SGN) cell bodies are surrounded by unmyelinated SGCs. **b** Immunohistochemistry of a corresponding region in a formaldehyde-fixed specimen showing TUJ1-positive SGN cell bodies and axonal processes expressing TUJ1 (*green*) and MBP (*red*). The axonal processes (hillock) display regions with no myelin expression (approximately 50 μm). **c**, **d** Cx43 expression (*green dots*) is seen along the peripheral border of SGN soma between surrounding satellite glial cells (*arrow* in **d**). 3-D video shows the human SG and Cx43-immunoreactive dots superimposed on neuron cell bodies ([Supplementary material](#Sec13){ref-type="sec"}). **e** Higher magnification of a TUJ1-positive (*green*) human SG cell body. Cx43 labeling is in *red* (*arrows*). **f** TEM image of a human SG (normal hearing) showing a gap junction (*arrow*) between satellite glial cells (*SGC*, *left*) surrounding a Type 1 SGN (*right*). *Bars* 20 μm (**a**, **b**), 10 μm (**c**, **d**), 5 μm (**e**), 0.5 μm (**f**)

S-100 immunostaining labeled both SGCs enveloping neuronal cell bodies and SCs lining the myelinated nerve fibers. The DAPI-stained nuclei of neurons were large, round and weakly stained, while SGCs had strongly DAPI-stained nuclei (Fig. [3c](#Fig3){ref-type="fig"}--[e](#Fig3){ref-type="fig"}). Highly specific immunoreaction to Cx43 was seen in the human spiral ligament and stria vascularis. Cx43 labeling was seen both separately and co-expressed with Cx30. Typically, the epithelial cells of the spiral prominence expressed diffuse intra-cytoplasmic expression of Cx43 (Fig. [1f](#Fig1){ref-type="fig"}, [g](#Fig1){ref-type="fig"}). Abundant Cx43 expression was also seen in central glia in the transitional zone of the human auditory nerve (Fig. [1h](#Fig1){ref-type="fig"}).

TEM of GJs in human spiral ganglion; comparison with guinea pig {#Sec11}
---------------------------------------------------------------

TEM analyses showed the presence of GJs between SGCs surrounding the Type I neurons. Our findings indicated that GJs existed both between SGCs surrounding the same Type I neuron and between neighboring SGNs (Fig. [4c](#Fig4){ref-type="fig"}, [d](#Fig4){ref-type="fig"}). They had a length of 4--500 nm and the intercellular distance approximated 4 nm between adjoining cells. At times, the SGCs were foliated and we could not establish with certainty whether the GJs were located between different SGCs or between the foliated leaflets of the same SGC.Fig. 4Spiral ganglion mono-polar cells in deafness and satellite cell gap junctions (*GJ*). **a** Celloidin section showing SG in Rosenthal's canal---basal turn in a female, aged 52 at death. She had mumps at age 2 and was deaf thereafter. The histology shows cochlear and saccular degeneration with no structures remaining in the cochlea except for the spiral ligament and 12,000 mono-polar ganglion cells (no dendrites). The vascular supply is normal. Note the physical relationship between the neural perikarya and blood vessels (*arrows* in *inset*). **b** Graphic illustration of two human mono-polar or "amputated" SG cells with surrounding SGCs (*red*) together with results from immunohistochemistry (*\#TrkB* tyrosine kinase B receptor, *BDNF* brain-derived neurotrophic factor, *nNOS* nitric-oxide synthase, *GFL* GDNF family ligand, *C-ret*\* GFL receptor, *GFRalpha*\* GDNF family receptor alpha, *NTRN*\* neurturin, *hSGNs* human spiral ganglion cells, *SGCs* satellite glial cells, *GDNF* glial-cell-line-derived neurotrophic factor, \*\**Cx30* connexin 30, \*\**Cx36* connexin 36, *P75NTR*§ P75 neurotrophin receptor). **c**, **d** TEM of human SGN cell bodies surrounded by SGCs. GJs are seen between SGCs (*arrows*). Framed area in **c** is shown in higher magnification in **d**. \*See Liu and Rask-Andersen ([@CR20]); \#Liu et al. ([@CR23]); \*\*Liu et al. ([@CR21]); §Liu et al. ([@CR24]); Voltage-gated ion channels have not been verified in human SG. *Bars* 30 μm (**a**), 2 μm (**c**), 200 nm (**d**)

In the guinea pig, the number of SCs that make up the sheath increases proportionately with the volume of the neuron that it surrounds. SGN in guinea pig are smaller and so fewer SCs surround an SGN. In guinea pig and cat, we mostly found only one nucleus sitting within the soma (not shown). TEM of SGNs in the guinea pig cochlea is shown in Fig. [5](#Fig5){ref-type="fig"}. The surrounding SCs form several tight myelin layers and desmosomal-like contacts can frequently be seen, whereas typical GJ-like structures are missing.Fig. 5TEM of Type I spiral ganglion neuron in guinea pig cochlea. *Boxed areas* in **a** are shown at higher magnification in **b**, **c** (*SC* Schwann cell, *SGN* spiral ganglion neuron). The surrounding Schwann cell forms several tight myelin layers (**a**) followed by two or more (depending on the site at the neuron) loosely arranged membrane sheets (**b**). Desmosomal-like contacts (*arrow* in **c**) can frequently be seen, whereas typical GJ-like structures are missing. Bars 2 μm (**a**), 500 nm (**b**), 500 nm (**c**)

Discussion {#Sec12}
==========

The present study verifies our previous findings that SGCs tightly envelop the primary afferent neurons in the human SG (Liu et al. [@CR22], [@CR23]). In addition, we have substantiated the presence of Cx43 GJ subunits in man by using TEM and immunohistochemistry. GJs might create intercellular pathways for ions and second messengers (e.g., Ca^2+^, inositol triphosphate, cAMP, cGMP), metabolites (e.g., glucose, amino acids, glutathione, ATP) and neuroprotectants (e.g., adenosine) to reach neighboring cells. Such couplings have been found both between SGCs surrounding individual Type I cells and between SGCs of neighboring nerve cell bodies.

Cx43 is the most widely expressed connexin in vertebrate tissue (Nagy et al. [@CR27]; Yamamoto et al. [@CR45]; Procacci et al. [@CR34]) and is found between SGCs cells in the trigeminal ganglion (Vit et al. [@CR43]), dorsal root ganglia (Pannese [@CR32]; Hanani et al. [@CR12]) and autonomic ganglia (Hanani [@CR11]). Limited information is available about the SGCs and their reaction to damage in sensory ganglia. Animal SG architecture is highly different from that of man and confines the use of animal models to studying injury effects on auditory neurons. On being damaged, SGCs undergo structural changes and increase the expression of glial fibrillary acidic protein (Chudler et al. [@CR2]; Stephenson and Byers [@CR39]; Hanani et al. [@CR12]; Vit et al. [@CR43]). Effects of axotomy on mouse trigeminal ganglion and SGCs include increased neuronal excitability, increased ectopic firing and increased coupling between SGCs, especially between neighboring cells (Cherkas et al. [@CR1]). These effects are believed to play major roles in the induction of neuropathic pain. Similar changes can be detected after sensory deprivation, degeneration and inflammation (Hanani et al. [@CR12]; Pannese et al. [@CR33]; Huang and Hanani [@CR13]; Huang et al. [@CR14]; Villa et al. [@CR42]; Durham and Garret [@CR6]; Ohara et al. [@CR31]). SGCs and intercellular coupling are believed to regulate the ionic milieu around neurons and an alteration of Cx43 expression might cause changes in K^+^-buffering capacity resulting in lowered sensory thresholds and membrane physiological potential changes (Cherkas et al. [@CR1]).

Additional substantiation of the neuroprotective role of Cx43 has been described. This connexin is a widely distributed protein in GJs in astrocytes (Giaume et al. [@CR9]; Naus et al. [@CR30]). In heterozygote Cx43 null mice and astrocyte-specific Cx43 null mice, increased brain damage has been observed after induced ischemia (Nakase et al. [@CR28]). Furthermore, enhanced Cx43 immunoreactivity has been established in human brain following ischemia (Nakase et al. [@CR29]). Another phenomenon that might highlight the role of Cx43 as a neural shield are the findings of preconditioning, an endogenous mechanism whereby sub-lethal hypoxic exposure increases cellular resistance. Such conditioning has not been observed in Cx43 null mice. In assays in vitro, such reaction has only been seen in cells expressing Cx43 and it deteriorates after treatment with short interfering RNA or channel blockers (Lin et al. [@CR18]).

The distribution of connexins in the adult cochlea has previously been studied in rodents (Suzuki et al. [@CR40]; Cohen-Salmon et al. [@CR3], [@CR4]; Kikuchi et al. [@CR16]) and also in man (Liu et al. [@CR21]) with variable results. In recent publications, Liu et al. ([@CR22]) have described Cx43 expression in the human cochleae as revealed by using laser confocal immunofluorescence. Cx43 is expressed as small membrane-associated dots in the SGCs. Cx43 is also expressed in the spiral limbus and spiral ligament and rabbit anti-Cx43 antibody (Invitrogen) labels the tympanic covering layer beneath the basilar membrane and the pillar and supporting cells in the organ of Corti. Because of the various phosphorylated states at the multiple different serine residues during cytoplasmic maturation and synthesis, the immune-detection of Cx43 gives various results. Differences in this pattern are explained by diverse antibodies recognizing Cx43 in different phosphorylated states. As a result of intracellular trafficking, connexins can stain diffusely instead as membrane plaques. In the present study with both antibodies against Cx43 (ab1 and ab2), we detected Cx43 also in the lateral wall, often co-expressed with Cx30 (Fig. [1f](#Fig1){ref-type="fig"}, [g](#Fig1){ref-type="fig"}).

Corresponding Cx43-expressing channels have not been observed in guinea pig SGs. In addition, morphologic evidence of the occurrence of GJs has not been verified by TEM. GJs and Cx43 are expressed only in non-myelinated sensory ganglia. In man and especially in the apical region, SGCs form honeycomb-like structures enwrapping several clustered Type I neurons. Such clusters seem to increase after denervation (Fig. [4a](#Fig4){ref-type="fig"}). This suggests that cells are coupled and can act synchronously via Cx43, influencing nerve excitation synergistically in a larger number of primary afferents. Such coupling between SGCs, singly or between cells in clusters, might provide compensatory trophic support to neurons in case of the peripheral loss of dendrites. Physical interaction between cochlear neurons has been substantiated in a quantitative evaluation and computer-aided 3-D reconstruction of SGNs in patients with hearing loss (Felder et al. [@CR8]) and after long-term deafness (Glueckert et al. [@CR10]). Coupling between neighboring cells in human SG might increase resistance for further degeneration and neurons can persist as mono-polar or "amputated" cells without peripheral dendrites.

Human SGNs are generally believed to undergo retrograde degeneration as a result of peripheral sensory loss. This idea stems from results obtained from animal research in which the loss of hair cells, under experimental conditions, results in the breakdown of SGNs including their central axons (Spoendlin [@CR37]; Webster and Webster [@CR44]; Schuknecht [@CR36]). In man, however, the loss of hair and supporting cells does not necessarily result in such a significant loss in SGNs (Teufert et al. [@CR41]). Several human temporal bone studies have shown that ganglion cells might well survive, despite the loss of supporting and hair cells (Kerr and Schuknecht [@CR15]; Nadol et al. [@CR26]; Nadol [@CR25]; Zimmermann et al. [@CR46]; Cureoglu et al. [@CR5]; Kusunoki et al. [@CR17]). Indeed, in patients with total deafness and no existing hair or supporting cells, SGNs often prevail (Linthicum and Fayad [@CR19]). In an 89-year-old patient with total hearing loss since birth, Teufert et al. ([@CR41]) found a loss of hair cells and peripheral processes but 19,458 surviving ganglion cells. A similar case is shown in Fig. [4a](#Fig4){ref-type="fig"}.

Moreover, neural loss seems not to be significantly related to deafness duration, based on age-normative data, or to remaining supporting cell populations (Teufert et al. [@CR41]). The number of remaining ganglion cells is not influenced by surviving peripheral processes or dendrites. SG neurons survive in Rosenthal's canal despite the fibrous obliteration of the scala tympani as long as the vascular supply is present. Instead, ganglion cell loss might be a primary concomitant loss attributable to the disease process instigated by factors causing the loss of sensory components. A similar outcome has been noted by Nadol ([@CR25]), thereby establishing that, in profoundly deaf patients, the cause of hearing loss, rather than duration, is the most important determinant of SGN cell count in man.

Since CI performance is not influenced by dendrite loss (Fayad and Linthicum [@CR7]), we can infer that mono-polar neurons are electrically excitable and can transmit action potentials to the central nervous system even after long-term neural inactivity. Our results explain the functional durability of cochlear implants (Fig. [6](#Fig6){ref-type="fig"}).Fig. 6Representations of the cellular pattern of retrograde degeneration of SGNs in guinea pig and man. **a** *Left* SGNs in a normal cochlea with intact organ of Corti. *Right* Loss of organ of Corti with secondary loss of peripheral dendrites in an ossified cochlea. **b** *Top* In man, SGNs can survive as "mono-polar" cells with unbroken central projections following dendrite degeneration. *Bottom* In the guinea pig, peripheral loss of dendrites results in complete degradation of the bipolar neuron (Spoendlin [@CR38]). A final stage of the process is reached over a period of months. A decisive factor for nerve degeneration seems to be the loss of stimulation from inner ear sensory hair cells but supporting cells might also play a role. One feasible explanation for these species differences could be the myelin/cell architecture of the SGN cell soma. In human, the dendrite pole is consolidated through a concerted action of SGCs (*red cells*) involving Cx43-mediated GJ signaling. This prevents further degeneration. This coordination might explain the SGN perseverance and endurance of cochlear implant stimulation following long-term sensory deprivation in children and adults

Furthermore, as mono-polar neurons can endure in the human cochlea, an important consequence is the potential prospect for the regeneration or re-sprouting of the peripheral processes in the future. Currently, we are investigating mono-polar cells in more detail to shed further light onto these possibilities. Another significant aspect is the physiological background of tinnitus, a neuropathic pain analog. The observed changes after axotomy of the sensory nerve, such as increased SGC coupling together with increased neural excitation (Cherkas et al. [@CR1]), could also occur in certain forms of tinnitus and thus provide new perspectives on its pathophysiology.
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